Skip to main content
Daily Report

Daily Anesthesiology Research Analysis

06/24/2025
3 papers selected
3 analyzed

Three anesthesia-focused studies stand out today: a double-blind RCT shows opioid-free anesthesia (esketamine + dexmedetomidine + bilateral cervical plexus blocks) improves quality of recovery after thyroidectomy; a randomized trial demonstrates BMI-based PEEP (BMI/3 cmH2O) lowers driving pressure and postoperative loss of lung aeration; and a meta-analysis finds esketamine significantly reduces pediatric emergence delirium without prolonging PACU stay or increasing PONV.

Summary

Three anesthesia-focused studies stand out today: a double-blind RCT shows opioid-free anesthesia (esketamine + dexmedetomidine + bilateral cervical plexus blocks) improves quality of recovery after thyroidectomy; a randomized trial demonstrates BMI-based PEEP (BMI/3 cmH2O) lowers driving pressure and postoperative loss of lung aeration; and a meta-analysis finds esketamine significantly reduces pediatric emergence delirium without prolonging PACU stay or increasing PONV.

Research Themes

  • Opioid-free anesthesia and enhanced recovery
  • Personalized intraoperative ventilation strategies
  • Esketamine for preventing pediatric emergence delirium

Selected Articles

1. Opioid-Free Anesthesia Improved the Quality of Recovery After Thyroidectomy Through Pre-Emptive and Preventive Analgesia: A Randomized Controlled Trial.

76.5Level IRCT
Drug design, development and therapy · 2025PMID: 40552090

In a double-blind RCT of 204 thyroidectomy patients, opioid-free anesthesia with esketamine, dexmedetomidine, and bilateral superficial cervical plexus blocks increased QoR-15 by 9.4 points and improved sleep, pain, and PONV compared with opioid-based anesthesia, albeit with prolonged emergence. These findings support OFA as a patient-centered strategy for thyroid surgery with careful depth monitoring to mitigate delayed emergence.

Impact: High-quality randomized evidence demonstrates improved patient-reported recovery with an OFA regimen tailored to thyroidectomy, addressing the opioid-sparing agenda while quantifying a tradeoff (longer emergence).

Clinical Implications: Consider OFA (esketamine + dexmedetomidine + bilateral superficial cervical plexus blocks) for thyroidectomy to enhance QoR and reduce PONV and pain. Plan for potential prolonged emergence by optimizing dosing, depth monitoring (e.g., processed EEG), and PACU readiness.

Key Findings

  • QoR-15 score on POD1 was higher with OFA vs opioid-based anesthesia (mean difference 9.4; 95% CI 7.0–11.7).
  • OFA reduced postoperative pain burden and PONV and improved sleep quality.
  • OFA was associated with prolonged emergence, highlighting a safety/efficiency tradeoff.

Methodological Strengths

  • Double-blind randomized controlled design with trial registration
  • Patient-centered primary endpoint (QoR-15) and multiple relevant secondary outcomes

Limitations

  • Single procedure type and single regimen; generalizability to other surgeries uncertain
  • Prolonged emergence not fully mechanistically explored; optimal dosing requires further study

Future Directions: Multicenter trials comparing different OFA compositions and dosing to minimize emergence delay while preserving recovery benefits; cost-effectiveness and implementation studies.

BACKGROUND: Opioid-free anesthesia (OFA) is increasingly being adopted to provide effective analgesia and reduce opioid-related adverse events. However, existing literature on OFA remains contentious, and its impact on postoperative recovery following thyroidectomy has not been evaluated. Therefore, we examined the hypothesis that OFA enhances the early quality of recovery in patients undergoing thyroid surgery. METHODS: In this randomized controlled trial, 204 adult patients undergoing thyroidectomy were randomly assigned to receive either OFA (esketamine, dexmedetomidine, and bilateral superficial cervical plexus blocks) or opioid-based anesthesia (OBA, sufentanil and remifentanil). The primary outcome was the quality of recovery on the first postoperative day, assessed using the quality of recovery-15 scale. Secondary outcomes included sleep quality score, area under the curve of pain intensity. Anesthesia-related complications were also recorded. RESULTS: On the first postoperative day, the OFA group had a significantly higher quality of recovery-15 score versus the OBA group (137.6 [5.6] vs 128.2 [10.5], mean difference = 9.4, 95% CI, 7.0-11.7, CONCLUSION: We showed that with a pre-emptive and preventive analgesia effect, OFA improved quality of recovery, sleep quality, pain, and postoperative nausea and vomiting after thyroidectomy. However, a prolonged emergence recovery was observed when patients receiving OFA strategy, warranting further investigation to optimize agent design and monitoring method to balance the intraoperative anesthesia depth. NAME OF TRIAL REGISTRY: Chinese Clinical Trial Registry. REGISTRATION NUMBER: ChiCTR2300070794; URL: https://www.chictr.org.cn/showproj.html?proj=196152. Thyroid surgery is increasingly performed as day case procedures. With the goal of enhanced recovery, it is important to assess outcomes from the patient’s perspective. This double blind, randomized controlled trial aimed to examine the effect of opioid-free anesthesia (OFA) on subjective quality of recovery (QoR) in patients undergoing thyroid surgery compared to those receiving opioid-based anesthesia. Importantly, we found that OFA improved QoR, sleep quality, pain, and postoperative nausea and vomiting after thyroid surgery, although it was associated with an increased risk of prolonged emergence recovery. Although cumulative effects of OFA has been shown to potentially enhance the overall postoperative QoR after different surgeries, such as orthopedic and thoracoscopic surgeries, our results showed that the advantages of OFA for QoR, particularly for thyroid surgery, remains limited and contentious. It warrants further investigation to optimize agent design of OFA.

2. Adjustment of positive end-expiratory pressure based on body mass index during general anaesthesia: a randomised controlled trial.

75.5Level IRCT
Anaesthesia · 2025PMID: 40551551

In a patient-blinded randomized trial (n=60), setting PEEP to BMI/3 cmH2O reduced intraoperative driving pressure and decreased postoperative loss of lung aeration compared with a fixed PEEP of 5 cmH2O. This pragmatic rule individualized ventilation in non-cardiothoracic surgical patients without major lung disease.

Impact: Provides a simple, actionable PEEP rule (BMI/3) that improves lung mechanics and aeration, potentially standardizing individualized lung-protective ventilation during anesthesia.

Clinical Implications: For adults without significant lung disease undergoing general anesthesia, consider targeting PEEP ≈ BMI/3 cmH2O to lower driving pressure and mitigate postoperative atelectasis; integrate with low tidal volumes and recruitment as appropriate.

Key Findings

  • BMI-based PEEP (BMI/3 cmH2O) significantly reduced intraoperative driving pressure compared with standard PEEP 5 cmH2O.
  • Postoperative lung aeration loss was reduced with BMI-tailored PEEP.
  • Approach is pragmatic, patient-blinded, and easily implementable in non-cardiothoracic surgeries.

Methodological Strengths

  • Randomized, patient-blinded design
  • Objective physiologic and imaging endpoints (driving pressure, lung aeration)

Limitations

  • Single-center, small sample size limits generalizability
  • Clinical outcomes (e.g., PPCs) not powered/assessed as primary endpoints

Future Directions: Multicenter trials powered for postoperative pulmonary complications and oxygenation; evaluation in obese, lung disease, and high-risk cohorts; integration with individualized driving pressure targets.

INTRODUCTION: Lung-protective ventilation is essential for preventing postoperative pulmonary complications. While maintaining a low driving pressure and optimising PEEP is of importance, the ideal strategy remains contentious. This study evaluated whether adjusting PEEP based on BMI, compared with standard PEEP, could reduce driving pressure and peri-operative loss of lung aeration. METHODS: We conducted a randomised controlled, patient-blinded, single-centre superiority trial with two parallel groups. Adult patients undergoing surgery with general anaesthesia who required tracheal intubation were assigned randomly to either standardised PEEP (PEEP = 5 cmH RESULTS: Sixty patients were enrolled and allocated randomly. Adjustment of PEEP according to BMI/3 was associated with a significantly lower driving pressure, with a median (IQR [range]) of 8.9 (7.1-10.4 [5.2-14.9]) cmH DISCUSSION: In patients without major pulmonary disease who were undergoing non-cardiothoracic surgeries with tracheal intubation, adjusting PEEP based on a calculation of BMI/3 improved lung mechanics and reduced postoperative loss of lung aeration. This approach provides a straightforward and pragmatic method for individualising PEEP in patients undergoing general anaesthesia. Protecting the lungs during surgery is important to stop problems with breathing afterwards. One way to do this is by using the right air pressure when helping someone breathe with a machine. But doctors don't all agree on the best way to do this. This study looked at whether using air pressure based on a person's body size (BMI) is better than using the same air pressure for everyone. We did a study with two groups of adult patients who were having surgery and needed help breathing with a tube and machine. Some patients got the same air pressure (5 cmH

3. The effect of esketamine on emergence delirium in pediatric patients undergoing general anesthesia: a meta-analysis of randomized controlled trials.

72.5Level IMeta-analysis
Frontiers in pharmacology · 2025PMID: 40552148

Meta-analysis of 10 RCTs (n=853) shows esketamine reduces pediatric emergence delirium (RR 0.40) without prolonging PACU stay or increasing nausea/vomiting. Subgroup analyses suggest single bolus before induction or at the end of surgery is more effective than intraoperative infusion.

Impact: Synthesizes randomized evidence to inform a practical, opioid-sparing strategy for a common pediatric anesthesia complication with clear dosing/timing implications.

Clinical Implications: Consider esketamine to prevent emergence delirium in children, favoring a single bolus before induction or at surgery end. Incorporate into pediatric ERAS and PACU protocols; monitor hemodynamics and psychomimetic effects as per local standards.

Key Findings

  • Esketamine reduced emergence delirium by 60% (RR 0.40; 95% CI 0.30–0.53).
  • No increase in PACU length of stay or nausea/vomiting.
  • Single bolus dosing (pre-induction or end of surgery) outperformed continuous intraoperative infusion.

Methodological Strengths

  • Meta-analysis of randomized controlled trials with prespecified outcomes
  • Prospective registration (PROSPERO) and subgroup analyses on dosing strategy

Limitations

  • Heterogeneity across anesthetic techniques and surgical types; incomplete reporting of I2
  • Pediatric dose ranges and safety profiles may vary; limited long-term neurobehavioral data

Future Directions: Head-to-head RCTs of dosing/timing regimens, standardized PAED-based definitions, and safety monitoring for psychomimetic or hemodynamic effects; cost-effectiveness within pediatric ERAS.

BACKGROUND: The aim of this study was to investigate the effect of esketamine on emergence delirium in pediatric patients. METHODS: We searched Pubmed, Cochrane Controlled Register of Trials, and Embase from inception to December 2024. Studies were independently evaluated for inclusion criteria and exclusion criteria by two reviewers. The primary outcome was the incidence of emergence delirium during the post-anesthesia period. The secondary outcomes were the PAED scores, FLACC scores, PACU stay time, and the incidence of nausea and vomiting. RESULTS: Ten studies including 853 children were eligible for this meta-analysis. The pooled data revealed that esketamine administration significantly reduced the incidence of emergence delirium in pediatric patients (RR: 0.40, 95% CI: 0.30-0.53, P < 0.00001, I CONCLUSION: The administration of esketamine can reduce the incidence of emergence delirium without prolonging PACU stay time and increasing the risk of nausea and vomiting in pediatric patients. Subgroup analysis indicated that a single bolus esketamine before anesthesia induction or at the end of surgery would better reduce the risk of ED than intraoperative continuous infusion. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/view/CRD42024623667.